Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer’s disease
(2024) In Nature Aging 4(5). p.623-624- Abstract
Staging Alzheimer’s disease on the basis of the disease’s biological underpinnings might help with stratification and prognostication, both in the clinical setting and in clinical trials. We propose a staging model based on only five biomarkers, which are related to amyloid-β and tau pathologies in different ways and can be measured with a single sample of cerebrospinal fluid.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/e4004d77-7c24-443f-97a6-225c162ef087
- author
- Salvadó, Gemma
LU
and Hansson, Oskar
LU
- organization
- publishing date
- 2024-05
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Aging
- volume
- 4
- issue
- 5
- pages
- 2 pages
- publisher
- Springer
- external identifiers
-
- pmid:38594461
- scopus:85190268749
- DOI
- 10.1038/s43587-024-00618-y
- language
- English
- LU publication?
- yes
- id
- e4004d77-7c24-443f-97a6-225c162ef087
- date added to LUP
- 2025-01-10 13:24:19
- date last changed
- 2025-11-15 16:17:47
@misc{e4004d77-7c24-443f-97a6-225c162ef087,
abstract = {{<p>Staging Alzheimer’s disease on the basis of the disease’s biological underpinnings might help with stratification and prognostication, both in the clinical setting and in clinical trials. We propose a staging model based on only five biomarkers, which are related to amyloid-β and tau pathologies in different ways and can be measured with a single sample of cerebrospinal fluid.</p>}},
author = {{Salvadó, Gemma and Hansson, Oskar}},
language = {{eng}},
number = {{5}},
pages = {{623--624}},
publisher = {{Springer}},
series = {{Nature Aging}},
title = {{Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer’s disease}},
url = {{http://dx.doi.org/10.1038/s43587-024-00618-y}},
doi = {{10.1038/s43587-024-00618-y}},
volume = {{4}},
year = {{2024}},
}